Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection

Ähnliche Einträge

• Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
  von: Cui Xiaohong, et al.
  Veröffentlicht: (2008-04-01)
• Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome
  von: Cui Xiaohong, et al.
  Veröffentlicht: (2008-11-01)
• Circularization and cleavage of guinea pig cytomegalovirus genomes.
  von: McVoy, M A, et al.
  Veröffentlicht: (1997)
• Inclusion of the Guinea Pig Cytomegalovirus Pentameric Complex in a Live Virus Vaccine Aids Efficacy against Congenital Infection but Is Not Essential for Improving Maternal and Neonatal Outcomes
  von: Mark R. Schleiss, et al.
  Veröffentlicht: (2021-11-01)
• An Attenuated Cytomegalovirus Vaccine with a Deletion of a Viral Chemokine Gene Is Protective against Congenital CMV Transmission in a Guinea Pig Model
  von: Michael P. Leviton, et al.
  Veröffentlicht: (2013-01-01)